BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29506751)

  • 1. BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.
    Chou A; Kim Y; Samra JS; Pajic M; Gill AJ
    Pathology; 2018 Apr; 50(3):345-348. PubMed ID: 29506751
    [No Abstract]   [Full Text] [Related]  

  • 2. RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.
    Chou A; Brown IS; Kumarasinghe MP; Perren A; Riley D; Kim Y; Pajic M; Steinmann A; Rathi V; Jamieson NB; Verheij J; van Roessel S; Nahm CB; Mittal A; Samra J; Gill AJ
    Mod Pathol; 2020 Apr; 33(4):657-664. PubMed ID: 31558784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
    Wang L; Basturk O; Wang J; Benayed R; Middha S; Zehir A; Linkov I; Rao M; Aryeequaye R; Cao L; Chmielecki J; Ross J; Stephens PJ; Adsay V; Askan G; Balci S; Klimstra DS
    Mod Pathol; 2018 Jan; 31(1):132-140. PubMed ID: 28884748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
    Ghosh T; Greipp PT; Knutson D; Kloft-Nelson S; Jenkins S; Mounajjed T; Said S; La Rosa S; Vanoli A; Sessa F; Naini BV; Bellizzi A; Zhang L; Kerr SE; Graham RP
    Arch Pathol Lab Med; 2022 Jul; 146(7):840-845. PubMed ID: 34614142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAF1 rearrangements are common in pancreatic acinar cell carcinomas.
    Prall OWJ; Nastevski V; Xu H; McEvoy CRE; Vissers JHA; Byrne DJ; Takano E; Yerneni S; Ellis S; Green T; Mitchell CA; Murray WK; Scott CL; Grimmond SM; Hofmann O; Papenfuss A; Kee D; Fellowes A; Brown IS; Miller G; Kumarasinghe MP; Perren A; Nahm CB; Mittal A; Samra J; Ahadi M; Fox SB; Chou A; Gill AJ
    Mod Pathol; 2020 Sep; 33(9):1811-1821. PubMed ID: 32358589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.
    Chmielecki J; Hutchinson KE; Frampton GM; Chalmers ZR; Johnson A; Shi C; Elvin J; Ali SM; Ross JS; Basturk O; Balasubramanian S; Lipson D; Yelensky R; Pao W; Miller VA; Klimstra DS; Stephens PJ
    Cancer Discov; 2014 Dec; 4(12):1398-405. PubMed ID: 25266736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
    Paoli C; Burel-Vandenbos F; Coulomb-l'Hermine A; Cros J; Pondrom M; Kubiniek V; Pedeutour F; Dadone-Montaudié B
    Genes Chromosomes Cancer; 2022 Dec; 61(12):734-739. PubMed ID: 35949061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
    Dewald GW; Smyrk TC; Thorland EC; McWilliams RR; Van Dyke DL; Keefe JG; Belongie KJ; Smoley SA; Knutson DL; Fink SR; Wiktor AE; Petersen GM
    Mayo Clin Proc; 2009 Sep; 84(9):801-10. PubMed ID: 19720778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
    Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
    J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
    La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
    Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and genetics of pancreatic neoplasms with acinar differentiation.
    Wood LD; Klimstra DS
    Semin Diagn Pathol; 2014 Nov; 31(6):491-497. PubMed ID: 25441307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of BRAF Kinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy.
    Klempner SJ; Bordoni R; Gowen K; Kaplan H; Stephens PJ; Ou SH; Ali SM
    JAMA Oncol; 2016 Feb; 2(2):272-4. PubMed ID: 26562024
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features.
    Thompson ED; Wood LD
    Arch Pathol Lab Med; 2020 Jul; 144(7):808-815. PubMed ID: 31869246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonductal Pancreatic Cancers.
    Jun SY; Hong SM
    Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancer.
    La Rosa S; Bernasconi B; Frattini M; Tibiletti MG; Molinari F; Furlan D; Sahnane N; Vanoli A; Albarello L; Zhang L; Notohara K; Casnedi S; Chenard MP; Adsay V; Asioli S; Capella C; Sessa F
    Virchows Arch; 2016 Mar; 468(3):289-96. PubMed ID: 26586531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.
    Caria P; Cantara S; Frau DV; Pacini F; Vanni R; Dettori T
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/PTC rearrangement occurring in primary peritoneal carcinoma.
    Flavin R; Jackl G; Finn S; Smyth P; Ring M; O'Regan E; Cahill S; Unger K; Denning K; Jinghuan Li ; Aherne S; Tallini G; Gaffney E; O'Leary JJ; Zitzelsberger H; Sheils O
    Int J Surg Pathol; 2009 Jun; 17(3):187-97. PubMed ID: 19147513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.